Srivastava P
J Clin Invest. 2024; 134(5).
PMID: 38426497
PMC: 10904052.
DOI: 10.1172/JCI176740.
McGranahan T, Li G, Nagpal S
Ther Adv Med Oncol. 2017; 9(5):347-368.
PMID: 28529551
PMC: 5424864.
DOI: 10.1177/1758834017693750.
Chen D, Mellman I
Nature. 2017; 541(7637):321-330.
PMID: 28102259
DOI: 10.1038/nature21349.
Srivastava P
Cancer Immunol Res. 2015; 3(9):969-77.
PMID: 26342008
PMC: 6722432.
DOI: 10.1158/2326-6066.CIR-15-0134.
Karimi S, Chattopadhyay S, Chakraborty N
Immunology. 2014; 144(2):186-96.
PMID: 25243729
PMC: 4298413.
DOI: 10.1111/imm.12387.
Oncolytic viruses as anticancer vaccines.
Woller N, Gurlevik E, Ureche C, Schumacher A, Kuhnel F
Front Oncol. 2014; 4:188.
PMID: 25101244
PMC: 4104469.
DOI: 10.3389/fonc.2014.00188.
Heat shock proteins, autoimmunity, and cancer treatment.
Calderwood S, Stevenson M, Murshid A
Autoimmune Dis. 2012; 2012:486069.
PMID: 23056925
PMC: 3465951.
DOI: 10.1155/2012/486069.
Heat shock proteins: conditional mediators of inflammation in tumor immunity.
Calderwood S, Murshid A, Gong J
Front Immunol. 2012; 3:75.
PMID: 22566956
PMC: 3342006.
DOI: 10.3389/fimmu.2012.00075.
The role of heat shock proteins in antigen cross presentation.
Murshid A, Gong J, Calderwood S
Front Immunol. 2012; 3:63.
PMID: 22566944
PMC: 3342350.
DOI: 10.3389/fimmu.2012.00063.
Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization.
Gavalas N, Karadimou A, Dimopoulos M, Bamias A
Clin Dev Immunol. 2011; 2010:791603.
PMID: 21318181
PMC: 3034919.
DOI: 10.1155/2010/791603.
Modeling the repertoire of true tumor-specific MHC I epitopes in a human tumor.
Srivastava N, Srivastava P
PLoS One. 2009; 4(7):e6094.
PMID: 19593447
PMC: 2704956.
DOI: 10.1371/journal.pone.0006094.
"It is the antigen(s), stupid" and other lessons from over a decade of vaccitherapy of human cancer.
Buckwalter M, Srivastava P
Semin Immunol. 2008; 20(5):296-300.
PMID: 18715801
PMC: 6731373.
DOI: 10.1016/j.smim.2008.07.003.
The response of autologous T cells to a human melanoma is dominated by mutated neoantigens.
Lennerz V, Fatho M, Gentilini C, Frye R, Lifke A, Ferel D
Proc Natl Acad Sci U S A. 2005; 102(44):16013-8.
PMID: 16247014
PMC: 1266037.
DOI: 10.1073/pnas.0500090102.
Regulatory T cells and tumor immunity.
Chattopadhyay S, Chakraborty N, Mukherji B
Cancer Immunol Immunother. 2005; 54(12):1153-61.
PMID: 15868167
PMC: 11034277.
DOI: 10.1007/s00262-005-0699-9.
Potent antitumor effect elicited by superantigen-linked tumor cells transduced with heat shock protein 70 gene.
Huang C, Yu H, Wang Q, Ma W, Xia D, Yi P
Cancer Sci. 2004; 95(2):160-7.
PMID: 14965367
PMC: 11159597.
DOI: 10.1111/j.1349-7006.2004.tb03198.x.
The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein.
Matsutake T, Srivastava P
Proc Natl Acad Sci U S A. 2001; 98(7):3992-7.
PMID: 11274422
PMC: 31167.
DOI: 10.1073/pnas.071523398.
Heat shock proteins: the fountainhead of innate and adaptive immune responses.
Basu S, Srivastava P
Cell Stress Chaperones. 2001; 5(5):443-51.
PMID: 11189450
PMC: 312875.
DOI: 10.1379/1466-1268(2000)005<0443:hsptfo>2.0.co;2.
Antibodies to heat-shock protein 27 are associated with improved survival in patients with breast cancer.
Conroy S, Sasieni P, Amin V, Wang D, Smith P, Fentiman I
Br J Cancer. 1998; 77(11):1875-9.
PMID: 9667662
PMC: 2150354.
DOI: 10.1038/bjc.1998.312.
Rabbit cardiac and skeletal myocytes differ in constitutive and inducible expression of the glucose-regulated protein GRP94.
Vitadello M, Colpo P, Gorza L
Biochem J. 1998; 332 ( Pt 2):351-9.
PMID: 9601063
PMC: 1219489.
DOI: 10.1042/bj3320351.
Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale.
Livingston P, Zhang S, LLOYD K
Cancer Immunol Immunother. 1997; 45(1):1-9.
PMID: 9353421
PMC: 11037709.
DOI: 10.1007/s002620050394.
